A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
Saved in:
| Title: | A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. |
|---|---|
| Authors: | Bafaloukos, Dimitrios1, Linardou, Helena1 elinardou@otenet.gr, Aravantinos, Gerasimos2, Papadimitriou, Christos3, Bamias, Aristotelis3, Fountzilas, George4, Kalofonos, Haralabos P.5, Kosmidis, Paris6, Timotheadou, Eleni4, Makatsoris, Thomas5, Samantas, Epaminondas2, Briasoulis, Evangelos7, Christodoulou, Christos8, Papakostas, Pavlos9, Pectasides, Dimitrios10, Dimopoulos, Athanasios M.3 |
| Source: | BMC Medicine. 2010, Vol. 8, Special section p1-12. 12p. 2 Diagrams, 5 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
